We exist to maximise the quality of life for people with blood disorders

Multiple Myeloma Clinical Trials Appeal

PBI is committed to developing new treatments for blood cancers and facilitates patient participation in clinical trials to access potentially lifesaving treatments not currently available elsewhere. Your support will enable us to participate in testing new treatment options to improve the health outcomes for patients with blood disorders, including multiple myeloma.


Author: Anita Lee

Target amount: $2,147,483,647.00

Amount raised: $35.60


Participate in a clinical trial

PBI's Clinical Trials Unit actively runs numerous clinical trials and performs state-of-the-art research into bleeding and clotting disorders and blood cancers. We regularly take part in new clinical trials for improved treatments for blood disorders – this provides Western Australians with the opportunity to access new treatments.



Participate in a research project

PBI regularly participates in clinical trials to support improved treatments for blood disorders, providing Western Australians with the opportunity to access new treatments.



Our Impact


Biobanked samples for translational resesarch.


Partnering haematology centres in the Asia-Pacific.    


Clinical trial patient appointments.


Active clinical trials.

Make a donation

Please select a donation amount (required)
Set up a regular donationDonate

Latest news

  • ATAGI & THANZ COVID-19 Vaccine Statement

    For the latest COVID 19 Australian Vaccination information read the joint statement from ATAGI and THANZ on Thrombosis with Thrombocytopenia Syndrome (TTS) and the use of COVID-19 Vaccine AstraZeneca. Read more

Upcoming events

  • SAVE THE DATE - Another Bloody Breakfast!

    We are pleased to have a date for the next 'Another Bloody Breakfast'! Please mark Friday September 10 in your diary. To find out more and register your interest for this event, please head to the event page. Read more